Analysts expect Vanda Pharmaceuticals Inc. to report revenue of 66.92 M for Q3 26, against a range of 61.45 M to 72.39 M. The most recent reported quarter, Q2 26, came in at 50.53 M, a 12.3% miss against the 57.65 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 47.65 M | 53.19 M | 50.04 M | 52.59 M | 56.26 M | 57.22 M | 51.72 M | 50.53 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 54.36 M | 53.11 M | 51.99 M | 60.94 M | 62.14 M | 59.19 M | 57.52 M | 62.04 M | 72.39 M | 78.53 M | 79.25 M | 89.14 M | 94.52 M | 107.91 M | 93.05 M | 97.13 M | ||||||||||
| Low Estimate | 50.24 M | 46.42 M | 43.61 M | 51.74 M | 52.97 M | 55.51 M | 48.64 M | 53.26 M | 61.45 M | 68.94 M | 69.33 M | 83.29 M | 80.11 M | 88.94 M | 81.34 M | 91.15 M | ||||||||||
| Consensus Estimate | 52.30 M | 49.77 M | 47.80 M | 56.34 M | 57.56 M | 57.35 M | 53.08 M | 57.65 M | 66.92 M | 73.74 M | 74.29 M | 86.21 M | 87.32 M | 98.43 M | 87.20 M | 94.14 M |
Analysts expect Vanda Pharmaceuticals Inc. to report earnings per share of -0.71 for Q3 26, against a range of -0.77 to -0.65. The most recent reported quarter, Q2 26, came in at -1.04, a 89.1% miss against the -0.55 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.09 | -0.08 | -0.50 | -0.46 | -0.38 | -2.39 | -0.82 | -1.04 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.16 | -0.11 | -0.53 | -0.32 | -0.39 | -0.86 | -0.64 | -0.53 | -0.65 | -0.49 | -0.38 | -0.25 | -0.28 | -0.47 | -0.02 | 0.03 | ||||||||||
| Low Estimate | -0.18 | -0.11 | -0.59 | -0.38 | -0.43 | -0.98 | -0.70 | -0.57 | -0.77 | -0.53 | -0.42 | -0.29 | -0.30 | -0.55 | -0.02 | 0.03 | ||||||||||
| Consensus Estimate | -0.17 | -0.11 | -0.56 | -0.35 | -0.41 | -0.92 | -0.67 | -0.55 | -0.71 | -0.51 | -0.40 | -0.27 | -0.29 | -0.51 | -0.02 | 0.03 |
Pull Wall Street consensus for Vanda Pharmaceuticals Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=VNDA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "VNDA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=VNDA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();